Quality of Life in Patients with Osteoporotic Vertebral Compression Fractures

Overview

Journal J Bone Metab

Date 2017 Sep 29

PMID 28955695

Citations 19

Authors

Ho Jin Jung

Ye-Soo Park

Hyoung-Yeon Seo

Jae-Chul Lee

Ki-Chan An

Jin-Hyok Kim

Byung-Joon Shin

Tae Wook Kang

Si Young Park

Affiliations

Soon will be listed here.

Abstract

Background: This study aimed to evaluate quality of life (QOL) using the EuroQOL-5 dimensions (EQ-5D) index and to examine factors affecting QOL in patients with an osteoporotic vertebral compression fracture (OVCF).

Methods: This ambispective study used a questionnaire interview. Patients over 50 years old with an OVCF at least 6 months previously were enrolled. Individual results were used to calculate the EQ-5D index. Statistical analysis was performed, and factors related to QOL were examined.

Results: Of 196 patients in the study, 84.2% were female, with an average age of 72.7 years. There were 66 (33.7%) patients with multilevel fractures. Conservative management was used in 75.0% of patients, and 56.1% received anti-osteoporosis treatment. The mean EQ-5D index was 0.737±0.221 and was significantly correlated with the Oswestry disability index score (correlation coefficient -0.807, <0.001). The EQ-5D index was significantly correlated with age (Spearman's rho=-2.0, =0.005), treatment method (=0.005), and history of fracture (=0.044) on univariate analysis and with conservative treatment (<0.001) and osteoporotic treatment (=0.017) on multivariate analysis.

Conclusions: OVCF markedly lowers QOL in several dimensions for up to 12 months, even in patients who have healed. Treatment of osteoporosis and conservative treatment methods affect QOL and should be considered in OVCF management.

Citing Articles

Biomechanical and clinical evaluation of PSO, modified PSO and VCR treating OVCF kyphosis: a finite element analysis.

Li J, Xu L, Wang H, Liu Y, Sun Z, Wang Y Front Bioeng Biotechnol. 2024; 12:1445806.

PMID: 39717529 PMC: 11663649. DOI: 10.3389/fbioe.2024.1445806.

Clinical efficacy and outcomes of calcitriol combined with bisphosphonates in the treatment of postmenopausal osteoporosis: A quasi-experimental study.

Han K, Wang X Medicine (Baltimore). 2024; 103(45):e40171.

PMID: 39533562 PMC: 11557120. DOI: 10.1097/MD.0000000000040171.

Associations Between Physical, Cognitive, and Mental Health Domains of Post-Intensive Care Syndrome and Quality of Life: A Longitudinal Multicenter Cohort Study.

Tilburgs B, Simons K, Corsten S, Westerhof B, Rettig T, Ewalds E Crit Care Med. 2024; 53(1):e74-e86.

PMID: 39445920 PMC: 11698138. DOI: 10.1097/CCM.0000000000006461.

A4 Thoracolumbar Fracture Class Is Associated With a Greater Degree of Vertebral Height Loss in Conservatively Managed Patients.

Ghadiyaram A, Krishnakumar A, Leppo J, Rajagopal M, Poulos N, Opalak C Cureus. 2024; 16(8):e66402.

PMID: 39247015 PMC: 11379500. DOI: 10.7759/cureus.66402.

Clinical Outcomes and Safety Comparison of Vertebroplasty, Balloon Kyphoplasty, and Vertebral Implant for Treatment of Vertebral Compression Fractures.

Li T, Pang S, England R, Gong A, Botros D, Manupipatpong S AJNR Am J Neuroradiol. 2023; 44(11):1345-1351.

PMID: 37918938 PMC: 10631528. DOI: 10.3174/ajnr.A8031.

References

Lips P, Cooper C, Agnusdei D, Caulin F, Egger P, Johnell O . Quality of life in patients with vertebral fractures: validation of the Quality of Life Questionnaire of the European Foundation for Osteoporosis (QUALEFFO). Working Party for Quality of Life of the European Foundation for Osteoporosis. Osteoporos Int. 1999; 10(2):150-60. DOI: 10.1007/s001980050210. View

Hallberg I, Rosenqvist A, Kartous L, Lofman O, Wahlstrom O, Toss G . Health-related quality of life after osteoporotic fractures. Osteoporos Int. 2004; 15(10):834-41. DOI: 10.1007/s00198-004-1622-5. View

Chesnut 3rd C, Skag A, Christiansen C, Recker R, Stakkestad J, Hoiseth A . Effects of oral ibandronate administered daily or intermittently on fracture risk in postmenopausal osteoporosis. J Bone Miner Res. 2004; 19(8):1241-9. DOI: 10.1359/JBMR.040325. View

Shin C, Kim M, Shim S, Kim J, Yu S, Koo B . The prevalence and risk factors of vertebral fractures in Korea. J Bone Miner Metab. 2011; 30(2):183-92. DOI: 10.1007/s00774-011-0300-x. View

Harris S, Watts N, Genant H, McKeever C, Hangartner T, Keller M . Effects of risedronate treatment on vertebral and nonvertebral fractures in women with postmenopausal osteoporosis: a randomized controlled trial. Vertebral Efficacy With Risedronate Therapy (VERT) Study Group. JAMA. 1999; 282(14):1344-52. DOI: 10.1001/jama.282.14.1344. View

Suzuki N, Ogikubo O, Hansson T . The prognosis for pain, disability, activities of daily living and quality of life after an acute osteoporotic vertebral body fracture: its relation to fracture level, type of fracture and grade of fracture deformation. Eur Spine J. 2008; 18(1):77-88. PMC: 2615123. DOI: 10.1007/s00586-008-0847-y. View

Suzuki N, Ogikubo O, Hansson T . Previous vertebral compression fractures add to the deterioration of the disability and quality of life after an acute compression fracture. Eur Spine J. 2009; 19(4):567-74. PMC: 2899832. DOI: 10.1007/s00586-009-1162-y. View

Huang C, Ross P, Wasnich R . Vertebral fractures and other predictors of back pain among older women. J Bone Miner Res. 1996; 11(7):1026-32. DOI: 10.1002/jbmr.5650110721. View

Lee H, Park S, Lee S, Suh S, Hong J . Comparative analysis of clinical outcomes in patients with osteoporotic vertebral compression fractures (OVCFs): conservative treatment versus balloon kyphoplasty. Spine J. 2012; 12(11):998-1005. DOI: 10.1016/j.spinee.2012.08.024. View

10.

Lee Y, Jang S, Lee H, Park C, Ha Y, Kim D . Mortality after vertebral fracture in Korea: analysis of the National Claim Registry. Osteoporos Int. 2011; 23(7):1859-65. DOI: 10.1007/s00198-011-1833-5. View

11.

Gennari C, Agnusdei D, Camporeale A . Use of calcitonin in the treatment of bone pain associated with osteoporosis. Calcif Tissue Int. 1991; 49 Suppl 2:S9-13. DOI: 10.1007/BF02561370. View

12.

Kim S, Hwang J, Kim T, Hong Y, Jo M . Validity and reliability of the EQ-5D for cancer patients in Korea. Support Care Cancer. 2012; 20(12):3155-60. DOI: 10.1007/s00520-012-1457-0. View

13.

Reginster J, Minne H, Sorensen O, Hooper M, Roux C, Brandi M . Randomized trial of the effects of risedronate on vertebral fractures in women with established postmenopausal osteoporosis. Vertebral Efficacy with Risedronate Therapy (VERT) Study Group. Osteoporos Int. 2000; 11(1):83-91. DOI: 10.1007/s001980050010. View

14.

Kim D, Lee S, Lee H, Lee H, Chang S, Chung S . Validation of the Korean version of the oswestry disability index. Spine (Phila Pa 1976). 2005; 30(5):E123-7. DOI: 10.1097/01.brs.0000157172.00635.3a. View

15.

Carreon L, Bratcher K, Das N, Nienhuis J, Glassman S . Estimating EQ-5D values from the Oswestry Disability Index and numeric rating scales for back and leg pain. Spine (Phila Pa 1976). 2014; 39(8):678-82. DOI: 10.1097/BRS.0000000000000220. View

16.

Klazen C, Lohle P, de Vries J, Jansen F, Tielbeek A, Blonk M . Vertebroplasty versus conservative treatment in acute osteoporotic vertebral compression fractures (Vertos II): an open-label randomised trial. Lancet. 2010; 376(9746):1085-92. DOI: 10.1016/S0140-6736(10)60954-3. View

17.

Bliuc D, Nguyen N, Milch V, Nguyen T, Eisman J, Center J . Mortality risk associated with low-trauma osteoporotic fracture and subsequent fracture in men and women. JAMA. 2009; 301(5):513-21. DOI: 10.1001/jama.2009.50. View

18.

Bombardier C . Outcome assessments in the evaluation of treatment of spinal disorders: summary and general recommendations. Spine (Phila Pa 1976). 2000; 25(24):3100-3. DOI: 10.1097/00007632-200012150-00003. View

19.

Lyritis G, Mayasis B, Tsakalakos N, Lambropoulos A, Gazi S, Karachalios T . The natural history of the osteoporotic vertebral fracture. Clin Rheumatol. 1989; 8 Suppl 2:66-9. DOI: 10.1007/BF02207237. View

20.

Alexandru D, So W . Evaluation and management of vertebral compression fractures. Perm J. 2012; 16(4):46-51. PMC: 3523935. DOI: 10.7812/TPP/12-037. View